By InvitationNot Applicable

"Comparison of Spirulina Gels for Treating Stage II Grade B Periodontitis"

Egypt15 participantsStarted 2024-10-21

Plain-language summary

This randomized controlled clinical study investigates the effectiveness of Spirulina gel and Spirulina nanoparticles gel in treating Stage II Grade B periodontitis. The research aims to compare the two formulations in terms of clinical, radiological, and biochemical outcomes, such as pocket depth reduction, alveolar bone density improvement, and inflammatory marker levels. The study seeks to provide insights into the potential of Spirulina-based therapies for enhancing periodontal health.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * Patients with good systemic health. * Patients who can maintain good oral hygiene. * Attachment loss 3-4 mm and probing pocket depth ≤ 5mm. Exclusion criteria for this study include: · * Any systemic disease that affects the periodontium. · * Pregnant, postmenopausal women. · * People who take anti-inflammatory drugs, antibiotics, or vitamins within the previous 3 month. * People who use mouth washes regularly · * Participation in other clinical trials.

What they're measuring

Reduction in Probing Pocket Depth (PPD)

Timeframe: at baseline, 1 month , 3 months, 6 months

Trial details

NCT IDNCT06699654

SponsorKafrelsheikh University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-10-24

View on ClinicalTrials.gov More Periodontitis Stage II trials